VitaLeech Bioscience

VitaLeech Bioscience N.V. developed a recombinant enzyme for the treatment of periodontitis, a form of inflammation of the gum that may result in the loss of teeth.

Periodonditis is a widespread disorder among 40+ year-olds. Oral care products with a proven efficacy against periodontitis do not exist yet.

Portfolio: MedSciences Capital B.V.

Current product development stage: programme has stopped.